Shares of Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report) passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 43.62 and traded as high as GBX 48. Beximco Pharmaceuticals shares last traded at GBX 48, with a volume of 419,866 shares traded.
Beximco Pharmaceuticals Trading Down 2.0%
The stock has a market cap of £214.13 million, a P/E ratio of 0.02 and a beta of 0.25. The stock’s 50-day moving average is GBX 43.62 and its two-hundred day moving average is GBX 42.90. The company has a debt-to-equity ratio of 5.27, a current ratio of 4.13 and a quick ratio of 0.37.
About Beximco Pharmaceuticals
Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands. Since its inception, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines.
Read More
- Five stocks we like better than Beximco Pharmaceuticals
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
